ABE1861
Anti-CDK12 Antibody
from rabbit, purified by affinity chromatography
Sign Into View Organizational & Contract Pricing
All Photos(2)
Cyclin-dependent kinase 12, CDC2-related protein kinase 7, Cdc2-related kinase, arginine/serine-rich, Cell division cycle 2-related protein kinase 7, Cell division protein kinase 12, CrkRS, hCDK12
Recommended Products
biological source
rabbit
Quality Level
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human
species reactivity (predicted by homology)
mouse (based on 100% sequence homology), rat (based on 100% sequence homology)
technique(s)
immunoprecipitation (IP): suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
target post-translational modification
unmodified
Gene Information
human ... CDK12(51755)
General description
Cyclin-dependent kinase 12 (EC 2.7.11.22; EC 2.7.11.23; UniProt Q9NYV4; also known as CDC2-related protein kinase 7, Cdc2-related kinase, arginine/serine-rich, Cell division cycle 2-related protein kinase 7, Cell division protein kinase 12, CrkRS, hCDK12) is encoded by the CDK12 (also known as CRK7, CRKRS, KIAA0904) gene (Gene ID 51755) in human. CDK12 belongs to the CMGC Ser/Thr protein kinase subfamily of cyclin-dependent kinases (CDKs). Originally identified and characterized as an RNA Polymerase II C-terminal domain (CTD) kinase, CDK12 is involved in the 3′ end processing of the MYC and c-FOS mRNA transcripts. In addtion, CDK12/CyclinK complex is implicated in the maintenance of genomic stability through the regulation of DNA damage response genes and as a determinant of PARP1/2 inhibitor sensitivity in cancer treatment. Human CDK12 is uncharacteristically large with a molecular weight of ∼160 kDa (most CDKs are about 50 kDa) and contains large N- and C-terminal extensions flanking the kinase domain (a.a. 727-1020). These extensions contain multiple stretches of low complexity sequence and RS domains characteristic of splicing factors and regulators believed to mediate protein-protein interactions. As expected of RS domain-containing proteins, CDK12 is found in nuclear speckles representing storage sites for splicing factors.
Specificity
Immunogen sequence is present in all spliced isoforms of human, mouse, and rat CDK12 reported by UniProt (Q9NYV4, Q14AX6, and Q3MJK5).
Immunogen
Linear peptide corresponding to an N-terminal sequence of human CDK12.
Application
Anti-CDK12 Antibody, Cat. No. ABE1861, is a highly specific rabbit polyclonal antibody that targets CDK12 and has been tested in Immunoprecipitation and Western Blotting.
Western Blotting Analysis: 0.2 µg/mL from a representative lot detected CDK12 in 45 µg of HeLa nuclear extract (Courtesy of Dr. Arno Greenleaf, Duke University, Durham, NC, U.S.A.).
Western Blotting Analysis: A representative lot detected baculovirus expressed human CDK12 in lysates from infected Sf9 cells (Bartkowiak, B., and Greenleaf, A.L. (2015). J. Biol. Chem. 290(3):1786-1795).
Western Blotting Analysis: A representative lot detected CDK12 in HeLa nuclear extract, as well as RNAi-mediated CDK12 downregulation in HEK293T/17 cells (Schwartz, J.C., et al. (2012). Genes Dev. 26(24):2690-2695).
Immunoprecipitation Analysis: Representative lots immunoprecipitated CDK12 from HeLa nuclear extract (Bartkowiak, B., and Greenleaf, A.L. (2015). J. Biol. Chem. 290(3):1786-1795; Schwartz, J.C., et al. (2012). Genes Dev. 26(24):2690-2695).
Western Blotting Analysis: A representative lot detected baculovirus expressed human CDK12 in lysates from infected Sf9 cells (Bartkowiak, B., and Greenleaf, A.L. (2015). J. Biol. Chem. 290(3):1786-1795).
Western Blotting Analysis: A representative lot detected CDK12 in HeLa nuclear extract, as well as RNAi-mediated CDK12 downregulation in HEK293T/17 cells (Schwartz, J.C., et al. (2012). Genes Dev. 26(24):2690-2695).
Immunoprecipitation Analysis: Representative lots immunoprecipitated CDK12 from HeLa nuclear extract (Bartkowiak, B., and Greenleaf, A.L. (2015). J. Biol. Chem. 290(3):1786-1795; Schwartz, J.C., et al. (2012). Genes Dev. 26(24):2690-2695).
Quality
Evaluated by Western Blotting in HeLa nuclear extract.
Western Blotting Analysis: 2.0 µg/mL of this antibody detected CDK12 in 10 µg of HeLa nuclear extract.
Western Blotting Analysis: 2.0 µg/mL of this antibody detected CDK12 in 10 µg of HeLa nuclear extract.
Target description
~200 kDa observed. Target band size appears larger than the calculated molecular weights of 164.2/163.2/141.4 kDa (human isoform 1/2/3), 163.7/139.9/162.8 kDa (rat isoform 1/2/3), and 163.8/140.0 kDa (rat isoform 1/2), likely due to posttranslational modifications such as phosphorylation. Uncharacterized band(s) may appear in some lysates.
Other Notes
Concentration: Please refer to lot specific datasheet.
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cancers, 14(7) (2022-04-13)
Type II testicular germ cell tumors (TGCT) are the most frequently diagnosed solid malignancy in young men. Up to 15% of patients with metastatic non-seminomas show cisplatin resistance and a very poor survival rate due to lacking treatment options. Transcriptional
Cancers, 15(8) (2023-05-16)
Osimertinib is a third-generation epidermal growth factor receptor and tyrosine kinase inhibitor (EGFR-TKI) approved for the treatment of lung adenocarcinoma patients harboring EGFR mutations. However, acquired resistance to this targeted therapy is inevitable, leading to disease relapse within a few
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service